BIOFILM FORMATION OF CANDIDA ALBICANS EXPOSED TO ETHANOL EXTRACT OF PROPOLIS by DJAIS, ARIADNA ADISATTYA et al.
ISSN - 0975-7058 
Vol 11, Special Issue 1, 2019
BIOFILM FORMATION OF CANDIDA ALBICANS EXPOSED TO ETHANOL EXTRACT OF PROPOLIS
ARIADNA ADISATTYA DJAIS1*, JEMMY2, NADHIFA PUTRI2, ANDIN RAHMANIA PUTRI2, RISQA RINA DARWITA3, 
BOY MUCHLIS BACHTIAR1
1Department of Oral Biology, Faculty of Dentistry, Universitas Indonesia, Indonesia, Jakarta 10430, Indonesia. 2Undergraduate Program, 
Faculty of Dentistry, Universitas Indonesia, Indonesia, Jakarta 10430, Indonesia. 3Department of Dental Public Health, Faculty of 
Dentistry, Universitas Indonesia, Jakarta 10430, Indonesia. Email: ariedjais26@gmail.com
Received September 12, 2018, Revised and Accepted  Desember 18, 2018
ABSTRACT
Objective: Propolis extract showed an excellent in vitro performance against yeast and was additionally found to be fungistatic and fungicidal. Propolis 
extract is also used for treatment and prevention of fungal infections. However, its effectiveness against Candida albicans biofilm formation requires 
investigation. The study evaluated the ability of propolis to inhibit C. albicans while the fungus is growing as a biofilm in vitro.
Methods: Two reference strains, C. albicans ATCC 25923 and a clinical strain (laboratory stock), were used in this study. For the biofilm experiment, 
the fungi were cultured in Tryptic Soy Broth medium with 1% sucrose and incubated at 37°C for 24 h, and different concentrations of ethanol extract 
of propolis were used as the inhibitor agents. Biofilm assays were performed in 96-well microtiter plates, quantification of the total biofilm biomass 
was performed using a crystal violet staining method, and the Student’s t-test was chosen for statistical analyses.
Results: Our data showed that 3 h incubation with propolis did not affect the biomass in the experimental group compared to the control. When the 
incubation time was extended to 18 h, the biomass increased significantly compared to the control.
Conclusion: This study showed that several concentrations of propolis did not inhibit biofilm. However, in each incubation time, we observed no 
hyphal morphology in the biofilm mass. Propolis might attenuate the opportunistic virulence of fungus growing as a biofilm in vitro. Further studies 
are necessary to confirm this phenomenon.
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INTRODUCTION
The yeast Candida albicans is an oral commensal microorganism that 
occurs in the oral cavity of 50%–70% of healthy individuals. This 
microbial can grow under anaerobic, aerobic, or aerobic conditions 
with 5% CO2 [1]. It is a polymorphic yeast and an opportunistic fungal 
pathogen that causes oral infections [1,2]. C. albicans has several 
gene families that encode proteins involved in pathogenesis and 
biofilm formation. Among these Aglutinin-like sequence (ALS) family 
that encodes cell-wall glycoproteins, some of which are involved in 
adherence to host surface [2]. C. albicans is distinguished from many 
other fungal species by its ability to form both yeast cells and hyphae 
under many different environmental conditions. Hyphae are an 
important structural component of C. albicans biofilms. The hyphae in 
biofilms contribute to the overall architectural stability of the biofilm, 
acting as a support scaffold for yeast cells and other hyphae. Thus, the 
ability to form hyphae and the ability of these hyphae to adhere to one 
another and to yeast cells are critical for normal biofilm development 
and maintenance [3].
Propolis is a honeybee product that is used to cover hive walls and 
fill gaps [4]. It consists of resins, balsams, bee wax essential oils, and 
other organic compounds collected from plants, buds, and exudates by 
honey bees. Its chemical composition includes 50% resin, 30% wax, 
10% essential oils, 5% pollen, and 5% other substances including 
minerals and organic compounds such as phenolic acids or their 
esters, flavonoids, terpenes, aromatic aldehyde and alcohol, fatty acids, 
stilbenes, and B-steroids [5]. The chemical composition of propolis is 
highly variable and depends on the local flora at the site of collection 
as well as on the season of collection [4,5]. Propolis also exhibits 
antimicrobial, anticancer, antifungal, antiviral, and anti-inflammatory 
properties that have gained attention in both the dental and medical 
fields. Propolis extract shows excellent performance against yeast 
during in vitro testing. In low concentrations, propolis extract is both 
fungistatic and fungicidal. Antifungals are used to treat and prevent 
fungal infections [6].
In spite of this, the efficacy of ethanol extract of propolis for inhibition 
of C. albicans biofilm formation remains unclear. Therefore, the aim of 
the present study was to investigate the effectiveness of propolis on the 
inhibition of C. albicans biofilm.
METHODS
Strains, growth conditions, and propolis extract
Two reference strains were used in this study, C. albicans ATCC 25923 
and an oral isolate obtained from the laboratory stock at the Oral 
Biology Laboratory, Faculty of Dentistry, University of Indonesia. In 
these experiments, all strains kept in a glycerol stock at −80°C were 
subcultured in Tryptic Soy Broth (TSB) medium with 1% sucrose and 
incubated at 37°C for 24 h.
Several concentrations of the ethanol extract of propolis (10%, 5%, and 
2.5%) were used in this study and were kindly provided by Dr. Sahlan 
from the Chemical Engineering Laboratory of the Engineering Faculty, 
University of Indonesia.
Biofilm formation in 96-well microtiter plates
Biofilm assays were carried out on 96-well microplates (TPP, 
Switzerland). Before the biofilm assay, the bottom of the microplate 
wells was coated with 100 μL of saliva sterilized by filtration containing 
200 µg/mL of protein that was measured with the Bradford method. 
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The microplate was then agitated for 5 min in a shaker (60 rpm) and 
incubated for 60 min at 37°C. The non-adherent salivary proteins were 
then removed. Subsequently, 200 µL of C. albicans (107 cells; optical 
density [OD]: 0.1) was added and the solution was incubated for 90 min 
at 37°C. The non-adherent cells were then removed by pipetting. 
Furthermore, 200 µL of different concentrations of ethanol extract of 
propolis (10%, 5%, and 2.5%) were added to the preformed biofilm in 
each well and incubated for 3 and 18 h at 37°C. After each incubation, 
the supernatants were removed and the formed biofilms were gently 
washed with 200 µL of PBS (pH 7.2).
Quantification of the total biofilm biomass
The total biofilm biomass was measured using the crystal violet (CV) 
staining method [7]. Briefly, after the incubation period wherein 
the biofilm was exposed to several propolis concentrations, the 
supernatants were removed and washed with 200 µL of PBS. At this 
point, the biofilms on the microplates were allowed to dry at room 
temperature, 200 µL of CV (0.5% v/v) was added to each well, and the 
microplate was then incubated for 15 min. The unabsorbed CV solution 
was removed and the absorbed CV was extracted using 96% ethanol. 
Finally, the absorbance was read using a microtiter plate reader 
(M965+Microplate Reader, Mertech Inc.) at 600 nm [7].
The inhibition and cell mass percentage were calculated using the 










All obtained data were expressed as mean ± standard deviation of 
triplicate experiments. A two-tailed Student’s t-test was used to 
determine the differences in biofilm formation between the control and 
treatment groups. p<0.05 was considered to be statistically significant.
RESULTS
The results of the biofilm assay showed that, when ethanol extract of 
propolis was added to the biofilm performed on the well and incubated 
for 3 h, the biofilm mass in both C. albicans strains tested decreased 
(Fig. 1). The absorbance value of group 0.784 of C. albicans ATCC 25923 
was 3.6 times increase from 0.216, while 0.706 of C. albicans wild 
type was 3.4 times increase from 0.209. However, compared to the 
control, there was no significant reduction in the biofilm mass in either 
experimental group (p>0.05). When the incubation time was extended 
to 18 h, the biomass in each treatment group increased significantly 
(p>0.05). The ODs of the 18-h incubation period were 3.777 and 3.649 
for the C. albicans ATCC 25923 and C. albicans wild type, respectively.
These phenomena were observed for all concentrations of propolis 
tested. On treatment with 2.5% ethanol extract of propolis, we observed 
an OD of 0.717 and 0.587 for C. albicans ATCC 25923 and C. albicans wild 
type, respectively, after the 3-h incubation. After the 18-h incubation, 
we observed an OD of 3.329 for C. albicans ATCC 25923 and 3.427 for 
C. albicans wild type (Fig. 1).
This study found that there was no inhibitory effect of all the selected 
concentrations of propolis on the C. albicans biofilm as the microbes 
were still viable (Table 1) during all the experimental time periods. The 
results of the exposure to 10% ethanol extract of propolis showed a 
growth of 72.44% and 94.46% for C. albicans ATCC 25923 and 69.12% 
and 94.90% for the C. albicans wild type following incubation for 3 
and 18 h, respectively. The results of the incubation with 5% ethanol 
extract of propolis showed a 67% and 93.80% growth for the C. albicans 
ATCC 25923 and 64.84% and 94.95% for the C. albicans wild type after 
incubation for 3 and 18 h, respectively. Concurrently, the 2.5% ethanol 
extract of propolis incubation showed a growth of 63.87% and 93.90% 
for C. albicans ATCC 25923 and 61.15% and 94.22% for wild-type after 
incubation for 3 and 18 h, respectively (Table 2).
The percentage of C. albicans biofilm cells after exposure to 10% 
ethanol extract of propolis was 362.96% and 1.807% for C. albicans 
ATCC 25923 and 323.85% and 1.961% for the C. albicans wild type 
after incubation for 3 and 18 h, respectively. The percentage of cells 
following incubation with 5% ethanol extract of propolis was 303.03% 
and 1.614% for C. albicans ATCC 25923 and 284.47% and 1.984% for 
C. albicans wild type and that for the 2.5% ethanol extract of propolis 
was 276.83% and 1.639% for C. albicans ATCC 25923 and 257.45% 
and 1.730% for C. albicans wild type after incubation for 3 and 18 h, 
respectively (Table 1).
DISCUSSION
In this study, biofilm inhibition following propolis exposure was 
observed after incubation for 3 and 18 h. The 3-h incubation period was 
chosen to represent the adhesion stage during biofilm formation. This 
is the first phase of supragingival biofilm formation on the coating of 
salivary components, known as acquired pellicle, on teeth surfaces [9]. 
The initial step of biofilm formation is adhesion [10]. This process relies 
on several cell wall proteins (CWPs) called adhesins. These proteins 
Fig. 1: Absorbance values at 3 and 18 h for several propolis concentrations of the Candida albicans ATCC 25923 and C. albicans wild type
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promote attachment to other epithelial and microbial cells or abiotic 
surfaces by binding to specific amino acid or sugar residues [10,11]. 
In general, adhesins are glycosylphosphatidylinositol (GPI)-dependent 
CWPs comprising a GPI anchor, serine/threonine domain, and 
carbohydrate or peptide domain [12]. In C. albicans, several adhesins 
belong to the ALS family [10,12], which is part of the GPI-CWP family. 
Another important family of adhesins in C. albicans is the hyphal wall 
protein (Hwp) family, including Hwp1 [10].
In addition to the 3-h incubation period, we observed the biofilm 
maturation stage after 18 h. Here, 18 h represents the intermediate 
(premature phase) of the biofilm formation. After adhesion, the biofilm 
development continues through morphologic modifications and 
increases in cell number and production of expandable polystyrene 
(EPS), which influence the biofilm architecture [10]. C. albicans 
alone produces matrix materials such as β-glucans, chitins, and β-N-
acetylglucosamine during biofilm formation in this time period. 
This appears to confer protection from antifungal agents. β-glucan 
is a component of the cell wall and is actively secreted by C. albicans 
during biofilm formation on silicone or polystyrene surfaces [13]. Thus, 
C. albicans biofilms have a variety of possible architectures, adhesion 
properties, cellular morphologies, and EPS compositions. For C. albicans 
biofilm formation in vitro, the early phase takes approximately 11 h, 
culminating in the formation of distinct microcolonies. The intermediate 
phase of the biofilm formation may last for 12–30 h and is characterized 
by the production of EPS and formation of a bilayer consisting of yeast, 
germ tubes, and/or young hyphal. The maturation process usually 
takes approximately 38–72 h [10].
We selected C. albicans for this study because its biofilm formation 
plays an essential role in the pathogenicity of C. albicans [12]. C. albicans 
infections rely on the organism ability to switch morphology between 
yeast cells and hyphae forms to adhere to surfaces, form biofilms, 
and penetrate tissues. Hyphae are believed to be invasive and the 
pathogenic forms of Candida species, whereas yeast is the commensal 
nonpathogenic form [14]. Biofilm is a cell mass that is surrounded by an 
extracellular matrix consisting of yeast cells and filaments. It has also a 
relationship with the surface and exhibits different phenotypic features 
than planktonic cells [10].
Biofilm model research findings vary depending on the laboratory 
materials and techniques used. Biofilm models can be difficult to 
compare due to differences in the biofilm formation times, growth 
mediums, and microbial species used in different environments [15]. 
Moreover, the medium used to evaluate biofilm formation in vitro is 
responsible to affect biofilm morphology [10].
In our study, TSB with 1% sucrose was used as nutritional support for 
C. albicans. This resulted in microbial growth after incubation for 3 and 
18 h. A sudden increase or decrease in the relative abundance of one or 
more species in a microbial community often indicates a homeostatic 
breakdown of the community. A common feature is a significant 
change in the nutrient status, such as the introduction of an excess of 
substrate such as a sugar or a chemical compound, which can disturb 
the ecosystem [16].
C. albicans has been detected more frequently in the oral cavities of 
children with ECC than in children without caries [1,17,18]. C. albicans 
and Streptococcus mutans are found together and interact within the 
conducive conditions of ECC [19]. Metabolic interactions are found 
between C. albicans and S. mutans. The lactic acid produced by S. mutans 
can be metabolized by C. albicans. C. albicans also increases the external 
pH by producing ammonia, leading to less cariogenic conditions [1]. 
However, the presence of C. albicans enhances the formation of oral 
biofilms [1,17].
C. albicans has the ability to interact with many bacterial species on 
different levels. The latter produce glucan that binds to the cell walls of 
C. albicans. Thus, yeast provides adhesion sites for bacteria, increasing 
dual-species biofilm formation. C. albicans was also found to exhibit a 
complex interaction with the cariogenic organism S. mutans [1]. In the 
oral cavity, C. albicans can interact and develop biofilms with S. mutans, 
greatly enhancing colonization by this organism on the teeth surfaces. 
A number of C. albicans and S. mutans were clearly higher than those 
observed in subjects with S. mutans only. This suggests that C. albicans 
might escalate the severity of ECC [17]. C. albicans also interacts with 
bacteria through chemical signaling in a process called quorum sensing 
(QS). S. mutans produces a small peptide called competence-stimulating 
peptide, which inhibits C. albicans hyphal formation during the early 
stages of biofilm formation [1].
To respond the changes in the biofilm environmental conditions after 
exposure to ethanol extract of propolis, it is necessary to examine the 
biomolecular level, including the QS molecule. Farnesol is a QS molecule 
that acts as an anti-biofilm agent [10,18]. It is produced by C. albicans 
and blocks the morphological transition from yeast to hyphae [10,18]. 
Hyphal development is important for the formation of substantial 
biofilm biomass [18]. In general, farnesol is mostly secreted in the 
later stages of biofilm formation by C. albicans [10]. Farnesol is an 
autoinducer molecule that influences the expression of genes involved 
in antifungal resistance, cell-wall maintenance, phagocytic responses, 
surface hydrophobicity, iron metabolism, and heat shock [10].
In this study, the growth of C. albicans was not inhibited by ethanol 
extract of propolis. This may be due to the diverse chemical composition 
of propolis. The bees of the subfamily Meliponinae, popularly known 
as stingless bees, are widespread over tropical and subtropical areas 
of the world [17]. Meliponinae are valuable pollinators of many crops, 
and most species produce honey together with wax and propolis. In 
spite of this, its chemical composition and biological activity are largely 
unknown. The composition of Meliponinae propolis samples is complex 
due to the heterogeneity of their chemical pattern. For instance, 
Meliponinae honey bee propolis had weak or no activity against the 
Gram-negative test strain Escherichia coli, and its action against C. 
albicans was also weak [19]. The chemical composition of propolis is 
highly variable and depends on the local flora at the site of collection and 
on the season of collection [4,5]. Despite potential intrinsic differences, 
which may depend on the propolis origin, it has been proven that most 
propolis variants have a wide-ranging therapeutic biological effects 
such as antimicrobial, antifungal, and antiviral activity [4].
CONCLUSION
This study showed that ethanol extract of propolis did not exert an 
inhibitory effect with respect to C. albicans growth. This held true 
for all concentrations of propolis tested. Further studies should be 
carried out to observe gene factors that contribute to the formation 
Table 1: Percentage of biomass cells associated with C. albicans 
biofilms
Propolis (%) C. albicans ATCC 
25923 (%)
C. albicans wild 
type (%)
3 h 18 h 3 h 18 h
10 362.96 1.807 323.85 1.961
5 303.03 1.614 284.47 1.984
2.5 276.83 1.639 257.45 1.730
C. albicans: Candida albicans
Table 2: Percentage of the growth of C. albicans biofilms
Propolis (%) C. albicans ATCC 
25923 (%)
C. albicans wild 
type (%)
3 h 18 h 3 h 18 h
10 72.44 94.46 69.12 94.90
5 67 93.80 64.84 94.95
2.5 63.87 93.90 61.15 94.22
C. albicans: Candida albicans
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of C. albicans biofilms, as influenced by propolis concentration. One 
example is the gene encoding farnesol, which is associated with QS, 
and the ALS gene, which is in turn associated with glucans formation. 
Furthermore, additional research is needed to validate the clinical 
results from examinations of dual oral microorganism biofilms, such 
those of C. albicans and S. mutans, which are closely associated with 
dental caries, exposed to ethanol extract of propolis.
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